‘FOCUS: The recent rebuke handed to a drugs manufacturer by a US regulator over the endorsement of its product by celebrity Kim Kardashian highlights differences in the way the direct marketing of prescription medicines is regulated in the US and UK.’
OUT-LAW.com, 13th August 2015
Source: www.out-law.com
